首页|环泊酚单用与复合舒芬太尼在肥胖患者无痛胃镜检查中的应用效果

环泊酚单用与复合舒芬太尼在肥胖患者无痛胃镜检查中的应用效果

扫码查看
目的:观察环泊酚单用与复合舒芬太尼在肥胖患者无痛胃镜检查中的应用效果.方法:选取 2022 年 1 月—2023 年 9 月于南昌市洪都中医院进行无痛胃镜检查的 80 例肥胖患者作为研究对象,使用随机数字表法将患者分为对照组与观察组,各 40 例.对照组单用环泊酚,观察组在对照组基础上复合舒芬太尼.对比两组麻醉质量、麻醉相关指标(麻醉起效时间、苏醒时间、定向力恢复时间及环泊酚药物总用量)、生命体征[心率(heart rate,HR)、平均动脉压(mean arterial pressure,MAP)及血氧饱和度(oxygen saturation of blood,SpO2)]及不良反应(低血压、呼吸抑制、体动反应、恶心呕吐、注射痛)发生情况.结果:观察组麻醉优良率(97.50%)高于对照组(80.00%),差异有统计学意义(P<0.05).观察组麻醉起效时间、苏醒时间、定向力恢复时间均早于对照组,环泊酚总用量少于对照组,差异均有统计学意义(P<0.05).麻醉前,两组HR、MAP及SpO2 水平比较,差异均无统计学意义(P>0.05),插入胃镜及拔出胃镜时,观察组HR、MAP及SpO2 水平均高于对照组,差异均有统计学意义(P<0.05).观察组不良反应总发生率(5.00%)低于对照组(25.00%),差异有统计学意义(P<0.05).结论:在肥胖患者无痛检查中运用环泊酚复合舒芬太尼麻醉相较于单用环泊酚,其麻醉效果更优,麻醉起效时间更快,检查完成后呼吸恢复、苏醒时间更短,麻醉药物使用量也更少,同时患者检查过程中生命体征更平稳,不良反应发生率较低.
Application Effects of Cipepofol Alone and Combined with Sufentanil in Painless Gastroscopy Examination of Obese Patients
Objective:To observe the application effects of Cipepofol alone and combined with Sufentanil in painless gastroscopy examination of obese patients.Method:A total of 80 obese patients who underwent painless gastroscopy examination in Nanchang Hongdu Hospital of TCM from January 2022 to September 2023 were selected as the study subjects,they were divided into the control group and the observation group by the random number table method,with 40 patients in each group.The control group was treated with Cipepofol alone,and the observation group was treated with Sufentanil on the basis of the control group.Anesthesia quality,anesthesia related indicators(onset time of anesthesia,awakening time,orientation recovery time and total dosage of Cipepofol),vital signs[heart rate(HR),mean arterial pressure(MAP)and oxygen saturation of blood(SpO2)],and incidence of adverse reactions(hypotension,respiratory depression,body movement,nausea and vomiting,and injection pain)in two groups were compared.Result:The excellent and good rate of anesthesia in the observation group(97.50%)was higher than that in the control group(80.00%),the difference was statistically significant(P<0.05).The onset time of anesthesia,awakening time,orientation recovery time in the observation group were earlier than those in the control group,and total Cipepofol dosage was less than that in the control group,the differences were statistically significant(P<0.05).Before anesthesia,there were no statistically significant differences in HR,MAP and SpO2 between the two groups(P>0.05);HR,MAP and SpO2 in the observation group were higher than those in the control group when inserting and removing the gastroscope,the differences were statistically significant(P<0.05).The total incidence of adverse reactions in the observation group(5.00%)was lower than that in the control group(25.00%),the difference was statistically significant(P<0.05).Conclusion:Applying Cipepofol combined with Sufentanil in painless gastroscopy examination of obese patients compared with Cipepofol alone,can achieve better anesthetic effect,faster onset of anesthesia,shorter time for respiration recovery and shorter awakening time after examination,less use of anesthetic drugs,and more stable vital signs during examination,with a lower incidence of adverse reactions.

CipepofolSufentanilObesityPainless gastroscopy

王长丽、张涛、刘颖

展开 >

南昌市洪都中医院麻醉科 江西 南昌 330000

江西省人民医院急诊创伤科 江西 南昌 330000

环泊酚 舒芬太尼 肥胖 无痛胃镜

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(23)